Best in Biotech 28 Oct 2025 Eight AI deals in 2025: Discover where industry leaders are betting big Artificial intelligence (AI) is rapidly transforming the biotechnology landscape, and as it does, we are seeing more and more strategic collaborations and partnerships focused on the technology. These partnerships make use of AI to analyze complex biological data, speed up drug discovery, and improve the design of clinical trials. By combining AI’s data-crunching capabilities with […] October 28, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Oct 2025 The 11 most advanced microbiome players aiming for the gut Take a look at 11 of the top biotech companies working on the development of gut microbiome therapies to treat a range of diseases. October 28, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2025 The ESMO 2025 digest: Is oncology in good shape? The 2025 edition of the European Society for Medical Oncology (ESMO) was held this week in Berlin, delve into its key highlights. October 24, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 24 Oct 2025Pichia pastoris: the microbial protein expression platform you’re probably underestimating Today we’re diving into the world of expression systems with Iskandar Dib, of Validogen and we’ll explore the remarkable potential of Pichia pastoris. October 24, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 22 Oct 2025 Deal after deal: Novartis spends billions in 2025 Novartis has been on a shopping spree of late. Find out about the pharma giant’s latest deals of 2025. October 22, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 22 Oct 2025 PCSK9’s second act: From antibodies to gene editing With Eli Lilly’s recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents. October 22, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Oct 2025 Seven of the top biotech companies to know about in South San Francisco Check out some of the top biotech companies with headquarters in South San Francisco, also known as the Birthplace of Biotechnology. October 21, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Oct 2025 Five latest advancements in Tourette’s syndrome research Discover recent Tourette’s syndrome research, highlighting emerging therapies and biotech advances in this neurological disorder. October 20, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 17 Oct 2025 NLS Days: How do things look for biotech in Sweden? As Labiotech attented the NLS Days this week, it was the occasion to learn more about the biotech industry in Sweden. October 17, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 17 Oct 2025Biotech royalty deals on the rise and here to stay In today’s episode, we welcome Clarke Futch, Chairman and CEO of HealthCare Royalty Partners, or HCRx, with a thirty year track record in biopharma investing. October 17, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 15 Oct 2025 Biotech in Luxembourg: five companies that have made their name As the biotech industry in Luxembourg gradually grows, let us take a look at five biotech companies that are flourishing in the field. October 15, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 15 Oct 2025 The advent of AI for peptide design: An emerging field Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for peptides? October 15, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email